pathogen, inhibit, infection, Hepatitis C virus, HCVProtease, HCV Protease, HCV, HCV IN 29, HCVIN29, HCV-IN-29, Inhibitor, replication, viral, etaCV
HCV-IN-29 is a small molecule compound that acts as an inhibitor of the hepatitis C virus (HCV). It is utilized in biochemical research to study viral replication mechanisms and has demonstrated inhibitory activity in both cell-based (in vitro) assays and animal model (in vivo) studies of HCV infection.
Molekulargewicht:
570.38
Reinheit:
99.89% (May vary between batches)
CAS Nummer:
[1009119-83-8]
Formel:
C26H32Cl4N6
Target-Kategorie:
HCV Protease
Anwendungsbeschreibung:
Solubility: DMSO:45 mg/mL (78.89 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten